UPDATE : Monday, December 17, 2018
상단여백
Celltrion Healthcare’s sell-off of domestic sales right raises window-dressing controversy
The Financial Supervisory Service has begun to inspect Celltrion Healthcare...
by Nam Doo-hyun  |  2018-12-17 12:48
라인
Samsung BioLogics’ market cap rises after accounting issue
Samsung BioLogics is still showing its robust status in the Korean stock ma...
by Nam Doo-hyun  |  2018-12-13 15:33
라인
‘Bispecific antibody market offers promising outlook’
The treatment market using bispecific antibodies is likely to grow rapidly,...
by Nam Doo-hyun  |  2018-12-12 16:27
라인
Samsung BioLogics, Celltrion shares soar despite uncertainty
The share prices of Samsung BioLogics and Celltrion rose Wednesday even tho...
by Lee Han-soo  |  2018-12-12 16:27
라인
Machine learning finds biomarker for rare Castleman Disease
Medidata, a cloud-based solution provider for clinical research, said it ha...
by Lee Hye-seon  |  2018-12-11 17:11
라인
Viromed finds prostate hyperplasia treatment effect in natural substance
A team of researchers at the Viromed’s natural product research group said ...
by Lee Han-soo  |  2018-12-11 14:55
라인
Samsung BioLogics resumes trading despite controversies
The Korea Exchange (KRX) has decided to allow continued trading of Samsung ...
by Lee Han-soo  |  2018-12-11 10:50
라인
Celltrion unveils clinical trial results for rituximab biosimilar in US
Celltrion Healthcare has presented a clinical trial, which showed the effic...
by Lee Han-soo  |  2018-12-06 11:11
라인
Samsung BioLogics, Saint-Gobain sign supply agreement
Samsung BioLogics said Wednesday that it has signed a single-use raw materi...
by Lee Han-soo  |  2018-12-05 14:01
라인
Chong Kun Dang launches world’s 1st 2nd-generation anemia biosimilar
Chong Kun Dang Pharmaceutical said Sunday that it has become the first comp...
by Lee Han-soo  |  2018-12-04 11:18
라인
‘Rules to be tougher on patent transfer due to ToolGen case’
As the regulation on the patent transfer to a company from universities and...
by Nam Doo-hyun  |  2018-11-29 11:48
라인
Celltrion wins FDA nod for rituximab biosimilar
Celltrion said Thursday that the U.S. Food and Drug Administration has appr...
by Lee Han-soo  |  2018-11-29 10:50
라인
Samsung BioLogics files administrative suit to refute accounting fraud ruling
Samsung BioLogics said it filed an administrative suit on Nov. 14 to nullif...
by Nam Doo-hyun  |  2018-11-28 15:30
라인
Pharmaceuticals, biotechs rise with KOSPI rebound
Shares of pharmaceutical and biotech companies moved up briskly on Monday, ...
by Nam Doo-hyun  |  2018-11-27 11:53
라인
Celltrion’s Remsima tops global sale of ₩1 trillion
Celltrion Healthcare said Thursday that Remsima, a biosimilar of Remicade t...
by Lee Han-soo  |  2018-11-23 14:54
라인
Operating income declines at top 10 biotechs on KOSDAQ
Top 10 biotech companies on the secondary KOSDAQ market posted significant ...
by Nam Doo-hyun  |  2018-11-22 11:15
라인
Celltrion CEO involved in alleged ‘gapjil’ scandal
Celltrion Chairman Seo Jung-jin has reportedly pulled a power trip – ...
by Lee Han-soo  |  2018-11-21 16:02
라인
US data crucial for Korean biosimilars after success in Europe
Korean biosimilar makers will find it more critical to achieve meaningful r...
by Nam Doo-hyun  |  2018-11-21 15:29
라인
FDA OKs sale of Celltrion's HIV biosimilar
Temixys, a biosimilar developed by Celltrion to treat the human immunodefic...
by Lee Han-soo  |  2018-11-21 12:57
라인
Intron Bio inks ₩750 billion licensing deal for anti-superbug drug
Intron Biotechnology said it has signed a landmark deal for an investigatio...
by So Jae-hyeon  |  2018-11-20 15:00
여백
여백
여백
Back to Top